• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy
Schlieren/Basel, Switzerland and South San Francisco, California, USA - October 3, 2008 -- Genentech, Inc. (NYSE: DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX: ROG) have entered into a collaboration...

Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines
Leiden, The Netherlands (October 3, 2008) - Dutch biopharma company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced that it received a National Institutes of Allergy and Infectious Diseases...

(This Press Release was issued by Caprion Proteomics Inc.) Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
Montreal, October 3, 2008 - Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the US National...

Critical Therapeutics, Inc. Announces Effectiveness of Registration Statement for the Proposed Merger with Cornerstone BioPharma Holdings, Inc.
LEXINGTON, Mass.-October 03, 2008--Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that the Securities and Exchange Commission, or the SEC, has declared effective its Registration Statement on Form S-4...

Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
PRINCETON, N.J., Oct. 3 -- Covance Inc. (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, today announced that it has closed its transaction with Eli Lilly and Company...

Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy
October 03, 2008 -- Genentech, Inc. (NYSE: DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX: ROG) have entered into a collaboration agreement, including a licence from GlycArt to Genentech, for the joint...

Natus Medical Completes Acquisition of NeuroCom International
October 03, 2008 -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it has completed its acquisition of privately held NeuroCom International, Inc. NeuroCom, based in Clackamas, Oregon, develops and...

Air Products, Drexel University and Shanghai Jiao Tong University Agree to Continue Unique "3-2 Program" for Exceptional Chinese Students
LEHIGH VALLEY, Pa. (October 3, 2008) - Air Products (NYSE:APD), Drexel University and Shanghai Jiao Tong University (SJTU) have agreed to continue their Joint Cooperation Agreement for an integrated "3-2 Program"...

Stem Cell Therapeutics Corp. Announces Final Payment to Transition Therapeutics Inc. to Complete the Acquisition of Intellectual Property
CALGARY, ALBERTA--(Oct. 3, 2008) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT") announces today that it has elected to pay the final installment of the intellectual property acquisition of Stem Cell...

Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
INDIANAPOLIS, Ind. and LAWRENCE, Kan., October 03, 2008 -- Eli Lilly and Company (NYSE: LLY) and privately-held Deciphera Pharmaceuticals, LLC today announced that the two companies have entered into a collaboration and...

NCI Renews M. D. Anderson Core Grant; Peers Bestow Outstanding Rating
October 02, 2008 -- The National Cancer Institute (NCI) has renewed The University of Texas M. D. Anderson Cancer Center's Cancer Center Support Grant, an essential step in extending the institution's elite status as a...

Lentigen Corporation and The United States Army Agree to Contract
Gaithersburg, MD (October 1, 2008) - Lentigen Corporation announced today that it has established a contract with the United States Army to extend the programs established in the initial agreement announced in 2006....

NAMSA and Bionovus Life Sciences Partner to Keep Pace With Developing Market in Australia
Northwood, Ohio, September 30, 2008 - NAMSA, a worldwide leader in the safety evaluation of medical devices and manufacturer of sterilization assurance products, is pleased to announce our new partnership with Bionovus...

Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
PITTSBURGH--September 30, 2008--Cellumen, Inc. today announced an agreement with the Alzheimer's Drug Discovery Foundation (ADDF) to apply Cellumen's Cellular Systems Biology (CSB) technology to create acellular model...

Bayer starts new research cooperation in Asia
Berlin / Singapore, September 30, 2008 - Bayer Schering Pharma and the National University of Singapore (NUS) have agreed to cooperate in the field of pre-clinical cancer research. The initial collaboration with the NUS...

DSM and Crucell announce another key achievement for PER.C6
Groningen/Leiden, The Netherlands; Parsippany, USA, 29 September 2008 - DSM Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that the high-titer fed-batch process developed at the...

NeoGenomics Laboratories Extends Its Cancer Testing Services Through Exclusive Agreement with Response Genetics, Inc.
Fort Myers, Florida, September 29, 2008 - NeoGenomics Laboratories (OTCBB: NGNM), a national clinical reference laboratory specializing in high-complexity, cancer-specific testing, announced today an exclusive agreement...

Shionogi Extends Research Partnership with MorphoSys
September 29, 2008 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that Shionogi & Co., Ltd., Osaka, Japan, has elected to extend its current license agreement covering the use of MorphoSys's...

Clarient Enters into Training and Consulting Agreement with University of Pennsylvania School of Medicine
ALISO VIEJO, Calif., Sep 29, 2008 -- Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced today that...

Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices
FRAZER, Pa., Sept. 29 -- Cephalon, Inc. (Nasdaq: CEPH) announced today it has finalized a previously announced agreement in principle with the U.S. Attorney's Office for the Eastern District of Pennsylvania, the U.S....

MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production
GAITHERSBURG, Md., September 29, 2008 -- MedImmune announced today that it has licensed its proprietary reverse genetics intellectual property to BIKEN, The Research Foundation for Microbial Diseases of Osaka University...

Cardinal Health plans to spin off Clinical and Medical Products businesses, creating global leader in medical technology
DUBLIN, Ohio, Sept. 29, 2008 - Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced plans for a tax-free spin-off of its clinical and...

Lumera Corporation to Hold Conference Call to Discuss Q3 2008 Results and Update on Merger Progress
BOTHELL, Wash., September 29, 2008 -- Lumera Corporation (NASDAQ:LMRA), a leader in photonic communications, will hold its quarterly conference call to discuss third quarter results on Tuesday, October 21, 2008 at 4:30...

GENOVIS SIGNS DISTRIBUTION AGREEMENT WITH BIOLEGIO
September 29, 2008 -- Today Genovis signed a distribution agreement with Biolegio for exclusive rights to sell and market Genovis products in Holland and Belgium and a non-exclusive right for Germany.

ELITE ANNOUNCES DRUG APPLICATION FILING FOR SYNTHETIC NARCOTIC ANALGESIC ACCEPTED BY FDA
Northvale, New Jersey, Monday, September 29, 2008: Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (AMEX: ELI) in collaboration with ThePharmaNetwork, LLC., announced today the acceptance by the U.S. Food and...

FDA Grants Permission For Export of Antigenics' Oncophage
NEW YORK -- September 29, 2008 -- Antigenics Inc. (NASDAQ: AGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted the necessary permission to allow for the export of Oncophage

Allscripts Sets Record Date for Previously Announced Special Cash Dividend
CHICAGO, Sept. 29 -- Allscripts Healthcare Solutions, Inc. ("Allscripts") (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare,...

Allscripts Announces Update on Allscripts-Misys Transaction
ICAGO, Sept. 29 -- Allscripts Healthcare Solutions, Inc. ("Allscripts") (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare,...

FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
INDIANAPOLIS, September 29, 2008 -- Eli Lilly and Company (NYSE: LLY) announced today it received approval from the U.S. Food and Drug Administration (FDA) for the use of ALIMTA(R) (pemetrexed for injection), in...

SGS Acquires the Servi
Seeptember 29, 2008-SGS is pleased to announce the acquisition of the PiD Group, a leading brazilian group specialising in valve calibration, maintenance, electrical assembly, testing, training and consultancy...

Orchid & Merck & Co., Inc. collaborate to develop novel anti-infective drugs
Chennai, India - September 29, 2008 -Orchid Chemicals & Pharmaceuticals Ltd (Orchid) and Merck & Co., Inc. (Merck owns an affiliate, MSD Pharmaceuticals Pvt. Ltd., a marketer and distributor of Merck pharmaceutical...

20/20 GeneSystems Receives $650,000 Award to Develop Test to "Personalize" Breast Cancer Therapies
ROCKVILLE, MD (September 29, 2008)--20/20 GeneSystems, Inc. ("20/20") announced today that the U.S. National Cancer Institute (NCI) has awarded the company a grant of $650,000 under its Small Business Innovative...

Cancer Research UK and Astex Therapeutics Join Forces to Develop New Anti-Cancer Treatment
29th September 2008; London UK - Cancer Research UK, Cancer Research Technology (CRT) - the charity's development and commercialisation arm - and Astex Therapeutics Limited announced today that they have agreed to take...

Welichem Announces Granting of Incentive Stock Options
BURNABY, BC, Sept. 26, 2008 - Welichem Biotech Inc. (the "Company") (TSX-V: WBI), announced that its Board of Directors has approved a granting of incentive stock options to directors, officers, employees and...

King Pharmaceuticals Responds to Alpharma Inc.
BRISTOL, TENNESSEE - September 26, 2008 - King Pharmaceuticals, Inc. (NYSE: KG) today issued the following statement in response to an announcement by Alpharma Inc. (NYSE: ALO) regarding King's offer to acquire Alpharma...

ALPHARMA BOARD OF DIRECTORS UNANIMOUSLY REJECTS KING PHARMACEUTICALS' UNSOLICITED TENDER OFFER AS "FINANCIALLY INADEQUATE"
Bridgewater, NJ...September 26, 2008...The Board of Directors of Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today filed with the Securities and Exchange Commission a...

Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition
September 26, 2008 -- Invitrogen Corporation (NASDAQ:IVGN) today announced that the syndication of the financing relating to its proposed acquisition of Applied Biosystems announced on June 12, 2008 has been completed.

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
LEXINGTON, Mass., September 26, 2008 -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that it has signed a development, license and commercialization agreement with Teva Pharmaceutical Industries Ltd. for...

Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - A Next Generation Anthrax Vaccine
September 26, 2008 -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract with BARDA/NIAID, valued at up to $29.7 million, to fund the further development of AV7909, a next generation...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
ANNAPOLIS, Md., Sept. 26, 2008-- PharmAthene, Inc. (Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of Allergy and...

Sanofi Pasteur Completes the Acquisition of Acambis
Paris, France, September 25, 2008 - Sanofi Pasteur announced today that Sanofi Pasteur Holding has successfully completed the acquisition of Acambis plc for

Solvay Solexis enters joint development agreement with Strategic Polymer Sciences to develop ultra-high-energy density capacitator materials
September 25, 2008-Solvay announces today that its affiliate for fluorinated speciality polymers, Solvay Solexis, has struck a joint development agreement with Strategic Polymer Sciences (SPS), specialised in polymeric...

RECOMMENDED ACQUISITION OF ACAMBIS PLC BY SANOFI PASTEUR HOLDING BY WAY OF SCHEME OF ARRANGEMENT
Cambridge, UK and Cambridge, Massachusetts - 25 September 2008 - The Board of Directors of Acambis plc ("Acambis") (LSE:ACM) and Sanofi Pasteur Holding ("Sanofi Pasteur") are pleased to announce that the Scheme of...

Memorandum of Understanding between Chungcheongbuk-do Province and AMAREX
September 25, 2008 - Germantown, MD: Governor Woo-Taik Chung of Province Chungcheongbuk-do, Republic of Korea, and Dr. Kazem Kazempour, President and CEO of AMAREX Clinical Research, Germantown, Maryland, executed a...

Lonza and Crucell enter into long term agreement
September 25, 2008 -- Lonza and Crucell N.V. entered into a co-exclusive global manufacturing, sales and distribution agreement related to the PERMEXCIS(TM) cell culture medium developed by Crucell for PER.C6

Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights
September 24, 2008-Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has entered into a definitive merger agreement to acquire Pharmacopeia (NASDAQ: PCOP), in a deal valued up to $70 million....

Cellumen Selected as Signature Partner of Drug Safety Executive Council
PITTSBURGH--September 23, 20089--Cellumen, Inc., a discovery toxicology company, today announced the company has been selected by the Drug Safety Executive Council (DSEC) as one of eight Signature Partners working to...

Philips and Osram conclude LED patent license agreement
September 23, 2008-Eindhoven, The Netherlands - Royal Philips Electronics N.V. (NYSE: PHG, AEX: PHI) and Osram have concluded a patent license agreement for LED-based technology used in luminaires.

TIBCO SPOTFIRE AND INTEGROMICS ANNOUNCE GENOMICS DATA ANALYSIS SOLUTION TO RADICALLY SPEED DRUG RESEARCH AND DEVELOPMENT
SOMERVILLE, Mass., - September 23, 2008 -TIBCO Software Inc. (NASDAQ: TIBX), together with INTEGROMICS, a provider of state-of-the-art software solutions for data management and data analysis in genomics, proteomics and...

Assignment and Licence Agreement
September 18, 2008-Oxonica plc ("Oxonica"), a leading international nanomaterials group, today announces that it has signed a strategic agreement relating to its Nanoplex(TM) technology with BD (Becton, Dickinson and...

OVATION Pharmaceuticals Acquires Rights To Commercialize Xenazine
DEERFIELD, Ill., September, 17, 2008 - OVATION Pharmaceuticals, Inc. announced today that it has acquired from Prestwick Pharmaceuticals the exclusive license in the United States to commercialize Xenazine

NUCLETRON ANNOUNCES STRATEGIC PARTNERSHIP WITH BRACHYSOLUTIONS
COLUMBIA, MD (September 17, 2008)-- Nucletron, a knowledge-based leader in radiation oncology, announced today a strategic partnership with BrachySolutions, a leader in modern breast brachytherapy, to jointly expand the...

NBTY Acquires Leading UK Food Specialty Retailer Julian Graves
RONKONKOMA, N.Y., September 17, 2008 -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced it has acquired Julian Graves, the UK's largest...

Tethys Bioscience Announces Acquisition of Lipomics Technologies
Emeryville, Calif. -- September 17, 2008 - Tethys Bioscience, Inc. announced today that it has acquired Lipomics Technologies of West Sacramento, Calif. Financial terms were not disclosed.

Microchip Biotechnologies, Inc. awarded contract under US Army Commercialization Pilot Program
Dublin, CA, September 17, 2008. Microchip Biotechnologies, Inc. (MBI) has been awarded a $625,000 contract under the inaugural US Army Commercialization Pilot Program for the development of a Universal Sample...

Biovail Acquires Prestwick Pharmaceuticals
TORONTO--Sept. 17, 2008--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced it has acquired Prestwick Pharmaceuticals, Inc., a privately held, U.S.-based pharmaceutical company that holds the Canadian and U.S....

MediCult Completes Acquisition of MediCult Italia S.p.A
September 17, 2008 -- MediCult a/s (OSE: MEC), a leader in Assisted Reproductive Technologies (ART), announced today the successful completion of its acquisition of a further 35% of MediCult Italia S.p.A and the...

Intendis and Photonamic Sign Licensing and Development Agreement on 5-Aminolevulinic Acid Patch Technology
Berlin, September 17, 2008 - Intendis GmbH and Photonamic GmbH and Co. KG announced that the two companies have signed a License and Development Agreement that grants Intendis exclusive access outside of the US to their...

Invitrogen and Applied Biosystems Announce Divisional Structure and Executive Leadership Team
CARLSBAD, Calif. & FOSTER CITY, Calif.-- September 17, 2008--Invitrogen Corporation (NASDAQ: IVGN) and Applied Biosystems Inc. (NYSE: ABI) today announced the divisional structure and the executive leadership team for...

VALEANT PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE CORIA LABORATORIES, LTD.
ALISO VIEJO, Calif., September 17, 2008 - Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has signed a definitive agreement to acquire Coria Laboratories, Ltd., a privately-held specialty...

Intendis and Photonamic Sign Licensing and Development Agreement on 5-Aminolevulinic Acid Patch Technology
Berlin, September 17, 2008 - Intendis GmbH and Photonamic GmbH and Co. KG announced that the two companies have signed a License and Development Agreement that grants Intendis exclusive access outside of the US to their...

Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
EDEN PRAIRIE, Minn.----Sept. 17, 2008--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that Merck & Co., Inc. has...

U.S. Department of Justice Awards Abt Associates Grant for Human Trafficking Study
Cambridge, Massachusetts, September 17, 2008 -- The U.S. Department of Justice has awarded Abt Associates a $358,000 grant to complete an assessment of the current sex trafficking demand reduction strategies in place in...

DSM and Caliber Therapeutics to develop novel drug delivery device
Heerlen,NL,17-Sep-2008-- Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical and Caliber Therapeutics, Inc. will partner on the...

DFB has signed a definitive agreement to sell its dermatology division Coria
September 17, 2008--(FORT WORTH, TX) - H. Paul Dorman, Chairman and Chief Executive Officer of Fort Worth-based DFB Pharmaceuticals, Inc., today announced that DFB has signed a definitive agreement to sell its...

Sequella Receives $2.3 Million NIH Grant for Development of Tuberculosis Antibiotic Drug SQ641
September 17, 2008-Rockville, Md. -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat infectious diseases of epidemic potential, today announced that it received a...

Affymetrix to Distribute Biotique XRAY Software
Reno, NV, September 17, 2008 - Biotique Systems announced today a distribution agreement with Affymetrix Inc allowing Affymetrix to distribute XRAY directly to its customers. XRAY is an easy to use but powerful gene...

Omeros and The Parkinson's Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
Seattle, Washington and Sunnyvale, California - September 17, 2008 - Omeros Corporation and The Parkinson's Institute and Clinical Center today announced that they have entered into a collaboration to evaluate a novel...

Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
MONTVALE, N.J., September 17, 2008 -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that it has amended its nicotinic alpha-7 receptor agonist agreement with Roche to expand the Phase 2 development program...

RIKEI STARTS TO SELL NATIONAL INSTRUMENTS-MADE GRIB ASIC CHIPS BY CONCLUDING A DISTRIBUTOR AGREEMENT WITH JAPAN NATIONAL INSTRUMENTS.
September 16, 2008-Rikei Corporation (Head Office: Shinjuku-ku, Tokyo, President & CEO: Katsuei Aoyagi) would like to announce it has concluded a distributor agreement with Japan National Instruments (Head Office:...

NuGEN and Hamilton Create Automated, Total Target Preparation Solution to Increase Throughput and Improve Gene Expression Analysis Workflow
San Carlos, Calif.--September 16, 2008-- NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and sample preparation systems, and the Hamilton Company, a world...

DIREVO Announces Sale of its Subsidiary DIREVO Industrial Biotechnology GmbH and Series A Financing
Cologne (Germany), September 16, 2008 - DIREVO Biotech AG announced today the sale of its fully owned subsidiary DIREVO Industrial Biotechnology GmbH that was incorporated recently for an undisclosed cash amount to a...

Cl
KANSAS CITY, Mo., and SANTIAGO, Chile -- Sept. 16, 2008 -- Cl

DIREVO Biotech Acquired by Bayer HealthCare
Cologne (Germany), September 16, 2008 - DIREVO Biotech AG announced today its acquisition by Bayer HealthCare in an all cash deal at a transaction value of EUR210 Million (approx. $300 Million). DIREVO Industrial...

Microsoft and Cray Team Up to Drive High Productivity Computing Into the Mainstream
SEATTLE, WA and REDMOND, WA, Sep 16, 2008 -- Supercomputer leader Cray Inc. (NASDAQ: CRAY) and Microsoft Corporation (NASDAQ: MSFT) today introduced the new Cray CX1 supercomputer pre-installed with Windows HPC Server...

Biomedical Advanced Research and Development Authority of the Department of Health and Human Services (BARDA) Awards Cleveland BioLabs Contract to Develop Protectan CBLB502
BUFFALO, NY, Sep 16, 2008 -- Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (DHHS) has...

MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
VALENCIA, Calif. & NEW YORK, September 16, 2008 -- MannKind Corporation (Nasdaq: MNKD) and Pfizer Inc (NYSE: PFE) announced today that MannKind will transition certain Exubera patients with a continuing need for inhaled...

Luitpold Pharmaceuticals/American Regent announces closing of exclusive sublicense of Venofer
September 16, 2008 -- Shirley, NY - Luitpold Pharmaceuticals, Inc. and its subsidiary, American Regent, Inc., announced the closing of its license agreement with Fresenius Medical Care following the U.S. Federal Trade...

GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
RESEARCH TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Sept. 16, 2008-- GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration...

Isogenica enters into an evaluation agreement with Pfizer
Cambridge, UK, September 16, 2008: Isogenica Ltd today announced that it entered into an agreement with Pfizer in which Isogenica's CIS display technology will be evaluated by Pfizer for its ability to generate...

Invitrogen Provides Update on Regulatory Review and Financing for the Applied Biosystems Acquisition
CARLSBAD, Calif.-- September 16, 2008--Invitrogen Corporation (NASDAQ: IVGN) today provided the following updates on regulatory and financing relating to the proposed acquisition of Applied Biosystems announced on June...

Update on Allscripts-Misys Transaction
CHICAGO, Sept. 16, 2008 -- Allscripts Healthcare Solutions, Inc. ("Allscripts") (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve...

Takeda Milestone Payment
Cambridge UK, 16 September 2008: Alizyme plc (LSE:AZM) is pleased to announce that it is to receive a US$3 million milestone payment from Takeda Pharmaceutical Company Limited ("Takeda") as a result of Takeda's decision...

Accuray Incorporated and IMPAC Medical Systems to Link CyberKnife
SUNNYVALE, Calif., September 16, 2008 - Accuray Incorporated (Nasdaq: ARAY) and IMPAC Medical Systems, Inc. announced today that they will collaborate to develop inter-operability between the CyberKnife

GSK and Xenoport announce submission of new drug application requesting FDA approval of Solzira(TM) for Restless Legs Syndrome
September 16, 2008, London, UK -- GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA)...

Venofer
September 16, 2008 -- Fresenius Medical Care and Luitpold Pharmaceuticals, Inc. have closed an exclusive license agreement covering the marketing and distribution of Venofer

Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
September 16, 2008 -- Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced the closing of an exclusive license agreement with Luitpold Pharmaceuticals,...

Evotec Participates in the Sale of Direvo Biotech to Bayer Healthcare
September 16, 2008 -- Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) announced today that the Company participates via convertible bonds in the sale of Direvo Biotech AG to Bayer HealthCare...

EPIX Pharmaceuticals Achieves Milestone from Collaboration with Cystic Fibrosis Foundation Therapeutics
LEXINGTON, Mass.-- September 16, 2008--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly...

Sequenom Acquires Exclusive License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
SAN DIEGO----Sept. 16, 2008--Sequenom, Inc. (Nasdaq: SQNM), a leading provider of genetic-analysis solutions, today announced that it has acquired exclusive worldwide rights (excluding Hong Kong) to digital PCR and...

Regeneron and Columbia University Enter Into a Strategic VelocImmune(R) Agreement to Discover Human Monoclonal Antibodies
TARRYTOWN, N.Y.----Sept. 16, 2008--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Columbia University today announced that they have entered into an agreement that will provide researchers at Columbia University...

Pharmacopeia and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound
September 16, 2008-Pharmacopeia (NASDAQ: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has identified a new lead for advancement in its alliance with...

ABI Selects SeqWright as an Expression Analysis Service Provider Utilizing TaqMan Technologies
FOSTER CITY , Calif. - September 16, 2008 - Applied Biosystems Inc. (NYSE:ABI) today announced that it has established a global service provider program for RNA expression analysis. The TaqMan

DSM and LibraGen sign agreement to co-develop transaminases for production of chiral amines
Parsippany, USA; Vienna, AUS; Toulouse, FR 16 September 2008 - DSM and LibraGen, a bacterial diversity-based process and discovery specialist, announced today that they have signed an agreement to co-develop new...

Bayer HealthCare acquires German DIREVO Biotech AG
Leverkusen, September 16, 2008 - Bayer HealthCare AG acquires the German biotech company DIREVO Biotech AG, Cologne. With the acquisition of the biotech company specialized in protein engineering, Bayer strengthens the...

Bayer HealthCare acquires German DIREVO Biotech AG
Leverkusen, September 16, 2008 - Bayer HealthCare AG acquires the German biotech company DIREVO Biotech AG, Cologne. With the acquisition of the biotech company specialized in protein engineering, Bayer strengthens the...

PLEXUS AWARDED MANUFACTURING CONTRACT WITH KIRBY LESTER
NEENAH, WI, September 15, 2008 -- Plexus Corp. (NASDAQ: PLXS) announced today that the Company has been awarded the primary contract to manufacture Kirby Lester pharmacy automation systems in its Buffalo Grove, IL...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us